Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Masato Morikawa

12PUBLICATIONS

21CO-AUTHORS

Tissue engineeringMolecular targetsNeural engineeringOrthodontics and dentofacial orthopaedicsPredictive and prognostic markers

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (12)

Sort by Publication Date:

|Jan 16, 2026

Loss of transcription factor ATOH8 activates TGF-β signaling and exacerbates glomerulosclerosis in podocytes.

Hiroko Hamatani, Akifumi Tabei, Shinichiro Ogawa

|May 14, 2025

OCT-2 Is Associated With Pro-Metastatic Epigenomic Properties of Triple-Negative Breast Cancer Cells.

Kazuki Ogikubo, Jun Nishida, Kei Takahashi-Yamashiro

|Jul 02, 2021

PRRX1 induced by BMP signaling decreases tumorigenesis by epigenetically regulating glioma-initiating cell properties via DNA methyltransferase 3A.

Ryo Tanabe, Kohei Miyazono, Tomoki Todo

|Dec 20, 2020

Anti-pyroptotic function of TGF-β is suppressed by a synthetic dsRNA analogue in triple negative breast cancer cells.

Yusuke Tamura, Masato Morikawa, Ryo Tanabe

|Sep 14, 2020

BMP-induced Atoh8 attenuates osteoclastogenesis by suppressing Runx2 transcriptional activity and reducing the Rankl/Opg expression ratio in osteoblasts.

Yuhei Yahiro, Shingo Maeda, Masato Morikawa

|May 01, 2020

TGFβ and EGF signaling orchestrates the AP-1- and p63 transcriptional regulation of breast cancer invasiveness.

Anders Sundqvist, Eleftheria Vasilaki, Oleksandr Voytyuk

Pageof 2

Frequent Collaborators

8 joint publications

Daizo Koinuma

5 joint publications

Kohei Miyazono

2 joint publications

Jun Nishida

2 joint publications

Shingo Maeda

2 joint publications

Carl-Henrik Heldin

1 joint publications

Taichi Kato

1 joint publications

Eleftheria Vasilaki

1 joint publications

Hirofumi Sawada

1 joint publications

Johan Ledin

1 joint publications

Hiroyuki Aburatani

Frequent Collaborators

8 joint publications

Daizo Koinuma

5 joint publications

Kohei Miyazono

2 joint publications

Jun Nishida

2 joint publications

Shingo Maeda

Top Related Videos

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay

Published on : Sep 14, 2021

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on : Aug 02, 2024

Modeling Astrocytoma Pathogenesis <em>In Vitro</em> and <em>In Vivo</em> Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Modeling Astrocytoma Pathogenesis <em>In Vitro</em> and <em>In Vivo</em> Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Published on : Aug 12, 2014

See more related videos

Top Related Videos

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay

Published on : Sep 14, 2021

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on : Aug 02, 2024

Modeling Astrocytoma Pathogenesis <em>In Vitro</em> and <em>In Vivo</em> Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Modeling Astrocytoma Pathogenesis <em>In Vitro</em> and <em>In Vivo</em> Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Published on : Aug 12, 2014

See more related videos